Author:
Williams Bethany Jill,Bottoms David,Clark David,Treanor Darren
Abstract
Diagnostic histopathology departments are experiencing unprecedented economic and service pressures, and many institutions are now considering digital pathology as part of the solution. In this document, a follow on to our case for adoption report, we provide information and advice to help departments create their own clear, succinct, individualised business case for the clinical deployment of digital pathology.
Subject
General Medicine,Pathology and Forensic Medicine
Reference18 articles.
1. Williams BJ , Bottoms D , Treanor DE . Future-proofing pathology: the case for clinical adoption of digital pathology.
2. Food and Drug Administration, USA. FDA allows marketing of first whole slide imaging system for digital pathology: News release. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm552742.html (last accessed 31 May 2017).
3. The diagnostic concordance of whole slide imaging and light microscopy: a systematic review;Goacher;Arch Pathol Lab Med,2017
4. Validation of digital pathology imaging for primary histopathological diagnosis
5. Validation of Whole Slide Imaging for Primary Diagnosis in Surgical Pathology
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献